🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

All prostate cancer patients should receive cardiovascular screening, as the same risk factors that lead to cancer may also contribute to heart disease. #ProstateCancer #AHA24 Current risk assessment tools often fall short for prostate cancer patients. #AHA24 These results

A session you should not miss! #AHA24 #Cardioonc Avirup Guha, MBBS, MPH, FICOS, FACC, FAHA, FESC International Cardio-Oncology Society

AHA Science Omar Makram Elsayed, MD MPH (Omar M Makram) JAHA AmericanHeartJ International Cardio-Oncology Society Harikrishnan Hyma Raman Priyanshu nain Tochi Okwuosa #GlobalEquityinHealth #CardioOnc Khurram Nasir NIH NHLBI @JoeCoresh MCG MCG Internal Medicine MCG Cardiology Fellowship Nickolas Stabellini, MD, PhD PHRI.ca Population Health Research Institute 🇨🇦 Darryl Leong Monday fun day at #AHA24 grateful to AHA Science for inviting us to present our talks in a session titled: Cardio-Oncology in the real world: Disparities and Health iniquities in cardiovascular and cancer outcomes x.com/docharikris/st…

Our #AHA24 presence from #cardioonc program at Georgia Cancer Center MCG on Thread Reader App threadreaderapp.com/thread/1857894… Overall theme and take homes Health disparities in cardiovascular disease (CVD) remain significant across the board. In cardio-oncology, especially with

🚨 Excited to share our latest work on CV adverse events of BTKIs in MCL patients! 🙌 Huge thanks to Anita Deswal for incredible mentorship & Preetesh Jain MD, DM, PhD for outstanding collaboration. Grateful for Hani Jneid MD's unwavering support 🩺💡 #CardioOnc #AHA24

🍃🚶‍♂️ New research in JACC Journals Advances reveals the powerful combo of 🌳#NatureScore and #walkability for ❤️health! 🌳💚 tinyurl.com/2jneskvp - Geospatial data can enrich our understanding of geospatial determinants of CVD Center for Health & Nature Omar Makram Elsayed, MD MPH (Omar M Makram) Khurram Nasir & Others

🚨I’m happy to see our work in JACC Journals Advances! We highlight how #NatureScore and #Walkability contribute to cardiovascular health 🫀 Hoping these insights pave the way for healthier, more informed communities! 🏃‍♂️🌲🚶‍♂️🌳 Special thanks to the amazing team & mentors 🙏💚

CVD risk is up to 3x higher in cancer patients, but traditional risk scores fail to account for cancer-specific factors. Nickolas Stabellini, MD, PhD helped us developed ML-driven, cancer-specific CVD risk scores that outperform conventional models. #CardioOnc #CancerCare #cardiosky

Grateful to work with an incredible team on such an important study! ML-driven #cancer-specific #CVD risk score could really outperform traditional models—addressing a critical gap in cardio-oncology. Excited to see its impact! #CardioOnc #CancerCare #MachineLearning

Got interested and want to give these cancer-specific CVD risk estimators a try? We've made it easy for you! Breast Cancer: calconic.com/calculator-wid… Colorectal Cancer: calconic.com/calculator-wid… Lung Cancer: calconic.com/calculator-wid…

Cancer specific cardiovascular risk score is now available for use through this research group comprising some of International Cardio-Oncology Society members including Dr Avirup Guha, MBBS, MPH, FICOS, FACC, FAHA, FESC and Susan dent. Great work to improve cardiovascular health of lung, colon and breast cancer survivors!

Ab#315 ASCO #GU25 by Tarek nahle Avirup Guha, MBBS, MPH, FICOS, FACC, FAHA, FESC 👉bit.ly/41aQmQQ 👉In SEER-Medicare database in pts w/ #prostatecancer 👉Low socioeconomic position associated w/⬆️risk of CV mortality, PCa specific-mortality & all-cause mortality👇OncoAlert UroToday.com PCF Science

Check out our work ASCO #GU25 presented by the new star 🌟 of our lab Tarek nahle 🎉

Happy Valentine’s Day with this great review article from our cardio-oncology partners: Assessment and Prevention in Cardio-Oncology: Beyond Traditional Risk Factors. Cardiol Clin. 2025 Feb;43(1):1-11. Avirup Guha, MBBS, MPH, FICOS, FACC, FAHA, FESC pubmed.ncbi.nlm.nih.gov/39551552/

🫀🎗️ It was a great opportunity to present alongside Cezar Iliescu at 4tsconference. Honored to be part of the first-ever dedicated cardio-oncology session for an interventional cardiology audience!! Anita Deswal Hani Jneid MD #CardioOnc #cardiotwitter

🔍 AI applications in cardio-oncology: ✅ AI-ECG models for early cardiotoxicity detection 📉 ✅ Imaging & multi-omics for personalized risk stratification 🧬 ✅ Real-time monitoring via wearable tech ⌚ Challenges? Data heterogeneity, bias & regulatory hurdles remain. Viraj Shah

💡 The future of AI in cardio-oncology? 🔹 Explainable AI for clinician trust 🔹 AI-driven drug discovery 🔹 Integrating AI into clinical workflows for real-time decision-making 📢 Time to bring AI to the bedside! Thoughts? 🤔 #CardioOnc #AIHealth 3/3 Sherry-Ann Brown, MD, PhD, FACC, FAHA

‼️🔔 Big news! Our latest review, led by the incredible Viraj Shah 🌟 with the invaluable mentorship of Avirup Guha, MBBS, MPH, FICOS, FACC, FAHA, FESC , is now out! Grateful for the mentorship and vision. Check it out! #CardioOncology #AI MCG Internal Medicine MCG

Here’s to my first review as a Cardio-Oncology researcher! Dive into our latest publication in Current Cardiology Reports on how AI is rapidly transforming the current state of Cardio-Oncology, with breakthroughs like AI-ECG 📈, Multimodal AI Imaging 🫀📸, and AI-Integrated

🎧 حلقة جديدة من ABCDE Podcast 🎙️ واللي بنبدأ بيها سلسلة جديدة عن Physician-Scientist Pathways in the U.S. ضيفنا النهاردة هو د. عمر مكرم السيد – أحد الأطباء المصريين اللي قدروا يجمعوا بين التميز في الشغل الإكلينيكي والبحث العلمي 👨‍⚕️🔬 Dr. Omar is currently a resident on the